The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Capecitabine (cape)-associated hand-foot skin reaction (HFS) as a clinical predictor of improved survival in patients (pts) with colorectal cancer.
Ralf Hofheinz
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Volker Heinemann
Consultant or Advisory Role - Merck Serono
Honoraria - Merck Serono
Research Funding - Merck Serono
Other Remuneration - Merck Serono
Ludwig Fischer von Weikersthal
No relevant relationships to disclose
Ruediger Paul Laubender
Honoraria - Merck Serono
Research Funding - Merck Serono
Other Remuneration - Merck Serono
Deniz Gencer
No relevant relationships to disclose
Iris Burkholder
No relevant relationships to disclose
Andreas Hochhaus
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Sebastian Stintzing
Honoraria - Merck Serono
Other Remuneration - Merck Serono